Know Cancer

or
forgot password
  • cancer clinical trials in chicago, IL

  • A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Chicago, Illinois 60674
    Breast Cancer
    Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients
    Children's Memorial Hospital
    Chicago, Illinois 60614
    Liver Transplantation, Immunosuppression
    Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
    NorthwesternUniv.Med.School/Robert H. Lurie Comp.Cancer Ctr
    Chicago, Illinois 60611
    Breast Cancer
    Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer
    Swedish Covenant Hospital

    Trial Locations
    Swedish Covenant Hospital
    Mercy Hospital and Medical Center
    Hematology and Oncology Associates
    Saint Joseph Hospital
    Northwestern University
    Jesse Brown Veterans Affairs Medical Center
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Rush University Medical Center

    Trial Locations
    Rush University Medical Center
    Swedish Covenant Hospital
    Hematology and Oncology Associates
    Saint Joseph Hospital
    Northwestern University
    Mount Sinai Hospital Medical Center
    University of Chicago Comprehensive Cancer Center
    John H Stroger Jr Hospital of Cook County
    Resurrection Healthcare
    University of Illinois
    Jesse Brown Veterans Affairs Medical Center
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
    University of Chicago Comprehensive Cancer Center
    Chicago, Illinois 60637-1470
    Neurofibromatosis Type 1, Plexiform Neurofibroma, Spinal Cord Neurofibroma
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Rush University Medical Center

    Trial Locations
    Rush University Medical Center
    Swedish Covenant Hospital
    Mercy Hospital and Medical Center
    Hematology and Oncology Associates
    Northwestern University
    Mount Sinai Hospital Medical Center
    University of Chicago Comprehensive Cancer Center
    John H Stroger Jr Hospital of Cook County
    Resurrection Healthcare
    Jesse Brown Veterans Affairs Medical Center
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer
    Northwestern University, Northwestern Medical Faculty Foundation
    Chicago, Illinois 60611-3013
    Breast Cancer
    Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Chicago, Illinois 60611
    Cervical Cancer, Endometrial Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    University of Chicago Cancer Research Center
    Chicago, Illinois 60637
    Prostate Cancer
    PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Chicago, Illinois 60674
    Non Hodgkin Lymphoma
    Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    Children's Memorial Hospital - Chicago
    University of Illinois Cancer Center
    Kidney Cancer
    Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Mercy Hospital and Medical Center
    Chicago, Illinois 60616
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Bevacizumab in Treating Patients With Recurrent or Progressive Glioma
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University

    Trial Locations
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Hematology-Oncology Associates of Illinois
    Brain and Central Nervous System Tumors
    Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
    Childrens Memorial Hospital

    Trial Locations
    Childrens Memorial Hospital
    University of Illinois
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Mesenchymoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans, Localized Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Vatalanib in Treating Patients With Recurrent or Progressive Meningioma
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University

    Trial Locations
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Hematology-Oncology Associates of Illinois
    Brain and Central Nervous System Tumors, Sarcoma
    Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
    Childrens Memorial Hospital

    Trial Locations
    Childrens Memorial Hospital
    University of Illinois
    Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    University of Illinois
    Chicago, Illinois 60612
    Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Treating Young Patients With Relapsed or Progressive Cancer
    Children's Memorial Hospital - Chicago
    Chicago, Illinois 60614
    Brain and Central Nervous System Tumors, Leukemia, Lymphoma, Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
    University of Chicago

    Trial Locations
    University of Chicago
    University of Chicago Comprehensive Cancer Center
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Regional Transitional Cell Cancer of the Renal Pelvis and Ureter, Stage III Bladder Cancer, Stage IV Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer, Urethral Cancer Associated With Invasive Bladder Cancer
    Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    Children's Memorial Hospital - Chicago
    Leukemia, Myelodysplastic Syndromes